AMNOG impact on European countries?! Joint webinar with Medvance
Related Content
July 14, 2026
Cutting Edge Conversations: Value, Access and Evidence - Biotech Market Access
Sponsor:
PRECISIONheor
OPEN Health
PRMA Consulting
July 14, 2026
Cell & Gene Therapies - Beginning with the End in Mind
Sponsor:
Magnolia Market Access
July 9, 2026
Filling the Gap: Integrating Patient-Generated Data into Real-World Evidence
Sponsor:
Veradigm
June 15, 2026
Network meta-analysis and its role in evidence-based decision-making
Sponsor:
ICON
June 15, 2026
Joint Clinical Assessment 2025: Pioneering Pathways for Oncology, Advanced Therapies & Rare Diseases
Sponsor:
ICON
June 12, 2026
Stay Ahead of the Game: Learn How to Conduct an Evidence-Based GVD Faster and Smarter to Improve Market Access
Sponsor:
DistillerSR
June 7, 2026
Webcast: Taking the Complexity Out of Leveraging Health Plan Price Transparency Data
June 7, 2026
Expediting drug product development and commercialization in global markets with global filing strategies
June 7, 2026
Looking Beyond Survival Data: Understanding the Value of Non-OS Endpoints in Oncology Reimbursement Decision-Making
June 7, 2026
The Biotech landscape: Market trends, priorities, predictions, and pathways to FDA approval
June 7, 2026
US Drug Pricing Reform: Potential impact on Pharma HEOR Evidence Generation - September 8th
June 7, 2026
Become an expert & hone your skills for Pharma, Biotech, Medical & Diagnostic Device launches
June 7, 2026
Informing Market Access Earlier in Clinical Development: Prospective RWE Research to Characterize Real World Patient Populations
Sponsor:
Self Care Catalysts, an Alira Health Company
June 7, 2026
Value-Based Agreements - Are We Going to See More or Less of Them?
Sponsor:
Actu-Real
June 7, 2026
Cutting Edge Conversations: Value, Access and Evidence - Biotech Market Access
Sponsor:
OPEN Health
PRECISIONheor
PRMA Consulting
Related Content
See it in Action
The Digital Backbone for Modern Life Sciences
Discover how one intelligent platform helps teams connect providers, workflows, approvals, compliance, data, and spend—so complex projects move faster with greater visibility and control.